Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
NCT01802034
Summary
A central goal of this data repository is to collect data from a large population of subjects with a variety of renal disease states. Cohorts will include subjects with diabetes, inflammatory/autoimmune and transplant related renal conditions. Additionally, the repository will have the capacity to store biospecimens and electronic data in control subjects without established renal disease. This initiative will provide an opportunity to compare data from various disease states and controls with the objective of determining clinical and biological factors that predict disease progression, response to therapy and identify discriminating noninvasive clinical and biological features that predict renal biopsy findings.
Eligibility
Key Inclusion Criteria: All Groups: * Males or females * 18 years of age and older * Willing and able to provide informed consent Native Biopsy Tissue Group: \- Require an initial kidney biopsy for medical necessity Native Kidney, Non-tissue Group: * Previously had a kidney biopsy and the tissue is not stored in this biorepository; or * Have diabetes and kidney disease and have not had a kidney biopsy Allograft Tissue Group: \- Have undergone a renal transplant and require a transplant biopsy for either surveillance or "for-cause" indications. Key Exclusion Criteria for all Groups: \- Inability to provide informed consent.
Conditions7
Locations1 site
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT01802034